No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Gene-sequencing Group Illumina Sees $1.47 Bn Q2 Impairment Charge Linked to Grail
Illumina to Take $1.47 Billion Goodwill Impairment Charge Related to Grail in Q2
Express News | Illumina Inc - Grail Spin-off Complete; Grail to Begin Regular Way Trading as "Gral" on June 25
Express News | Illumina Inc : Guggenheim Cuts Target Price to $138 From $159
Express News | Illumina Inc: Entered Into a 364-Day Delayed Draw Credit Agreement
Express News | Illumina Inc : RBC Cuts Target Price to $249 From $253
No Data